Buy Gujarat Themis Biosyn for target price of Rs 909

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Jan 7, 2023.

  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    457
    Likes Received:
    55
    Gujarat Themis Biosyn is held 74.99% by promoters. It changed business model from contract manufacturing to manufacturing & sales. Operating profitability has significantly improved. It reported robust numbers over FY20-22. Buy for target price of Rs 909

    Download research report

    [​IMG]
     
Loading...